Trial intelligence / Profile preview

Dexmedetomidine as an Adjuvant to Bupivacaine for Labor Pain

NCT07506044Recruiting

Sponsor
Menoufia University
Start
May 2026
Primary completion
Oct 2026
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of dexmedetomidine in labor pain (4 arms), sponsored by Menoufia University. Primary endpoint: Total dose of bupivacaine administered during labor. Started May 2026; status: recruiting.

02

Drugs

dexmedetomidine
03

Conditions

labor pain

Beyond the preview

Go deeper on NCT07506044.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07506044.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call